ArticleBlood2023

Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.

Joseph C Rimando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.